You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Article metrics

Article menu

Download PDFPDF

Research Article
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019770
Jan 202016162
Feb 2020666629
Mar 2020585825
Apr 202043436
May 2020505020
Jun 202031314
Jul 2020848418
Aug 2020333314
Sep 2020686819
Oct 202011111138
Nov 2020969730
Dec 2020535317
Jan 2021838432
Feb 2021656519
Mar 2021858526
Apr 2021424220
May 202113213236
Jun 2021565624
Jul 2021363624
Aug 2021373734
Sep 2021505045
Oct 2021494943
Nov 2021404131
Dec 2021474723
Jan 2022394119
Feb 2022929323
Mar 2022646413
Apr 2022485031
May 2022626435
Jun 2022283017
Jul 2022414422
Aug 2022595923
Sep 2022454518
Oct 2022383825
Nov 202215015240
Dec 2022454526
Jan 202331319
Feb 2023545418
Mar 2023282919
Apr 2023272731
May 2023343414
Jun 2023222214
Jul 2023404026
Aug 2023313123
Sep 2023232311
Oct 2023444418
Nov 2023333314
Dec 2023525223
Jan 2024505123
Feb 2024565622
Mar 2024545468
Total272827471204